ARTICLE | Company News

Actelion says J&J discussed deal

November 28, 2016 10:52 PM UTC

Actelion Ltd. (SIX:ATLN) acknowledged in a statement Friday that Johnson & Johnson (NYSE:JNJ) has approached it "about a possible transaction." Actelion declined further comment. The company markets hypertension drugs Uptravi selexipag, Opsumit macitentan and Tracleer bosentan...

BCIQ Company Profiles

Actelion Ltd.

Johnson & Johnson